Literature DB >> 19875303

WNT signaling in ovarian follicle biology and tumorigenesis.

Alexandre Boyer1, Alan K Goff, Derek Boerboom.   

Abstract

The WNTS are an expansive family of glycoprotein signaling molecules known mostly for the roles they play in embryonic development. WNT signaling first caught the attention of ovarian biologists when it was reported that the inactivation of Wnt4 in mice results in partial female-to-male sex reversal and oocyte depletion. More recently, studies using loss- and gain-of-function transgenic mouse models demonstrated the requirement for Wnt4, Fzd4 and Ctnnb1, components of the WNT pathway, for normal folliculogenesis, luteogenesis and steroidogenesis, and showed that dysregulated WNT signaling can cause granulosa cell tumor development. This review covers our current knowledge of WNT signaling in ovarian follicles, highlighting both the great promise and the many unresolved questions of this emerging field of research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875303     DOI: 10.1016/j.tem.2009.08.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  59 in total

Review 1.  Plasticity of granulosa cells: on the crossroad of stemness and transdifferentiation potential.

Authors:  Edo Dzafic; Martin Stimpfel; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2013-07-28       Impact factor: 3.412

2.  SFRP4 Is a Negative Regulator of Ovarian Follicle Development and Female Fertility.

Authors:  Gustavo Zamberlam; Evelyne Lapointe; Atefeh Abedini; Charlene Rico; Philippe Godin; Marilène Paquet; Francesco J DeMayo; Derek Boerboom
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

3.  β-catenin stabilization in gonadotropes impairs FSH synthesis in male mice in vivo.

Authors:  Derek Boerboom; Vikas Kumar; Alexandre Boyer; Ying Wang; Romain Lambrot; Xiang Zhou; Charlène Rico; Ulrich Boehm; Marilène Paquet; Christophe Céleste; Sarah Kimmins; Daniel J Bernard
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

4.  Body mass index in relation to extracellular vesicle-linked microRNAs in human follicular fluid.

Authors:  Rosie M Martinez; Andrea A Baccarelli; Liming Liang; Laura Dioni; Abdallah Mansur; Michal Adir; Valentina Bollati; Catherine Racowsky; Russ Hauser; Ronit Machtinger
Journal:  Fertil Steril       Date:  2019-05-27       Impact factor: 7.329

5.  Beta-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization.

Authors:  Heng-Yu Fan; Annalouise O'Connor; Manami Shitanaka; Masayuki Shimada; Zhilin Liu; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2010-07-07

Review 6.  Ovary and fimbrial stem cells: biology, niche and cancer origins.

Authors:  Annie Ng; Nick Barker
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-09       Impact factor: 94.444

Review 7.  Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly.

Authors:  Heng-Yu Fan; Zhilin Liu; Lisa K Mullany; JoAnne S Richards
Journal:  Mol Cell Endocrinol       Date:  2011-12-16       Impact factor: 4.102

8.  Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.

Authors:  Mijung Kwon; Soo Jin Lee; Yarong Wang; Yevangelina Rybak; Alex Luna; Srilakshmi Reddy; Asha Adem; Brian T Beaty; John S Condeelis; Steven K Libutti
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

9.  The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles.

Authors:  April K Binder; Karina F Rodriguez; Katherine J Hamilton; Patricia S Stockton; Casey E Reed; Kenneth S Korach
Journal:  Endocrinology       Date:  2013-04-11       Impact factor: 4.736

Review 10.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.